| 5-R21-EB033892-03 |
Engineered Probiotics for Closed-Loop Control of Disease-Associated Gut Metabolites in Gut-On-Chip Models |
Benjamin Woolston |
Northeastern University |
| 5-R01-EB035491-02 |
Engineering pluripotent stem cells to evade and promote immunity |
Christopher Sturgeon |
Icahn School of Medicine at Mount Sinai |
| 7-R21-EB030769-02 |
Engineering Probiotics to Sense and Respond to the Intracellular Redox Imbalances towards Mitochondrial Dysfunction |
Jiahe Li |
University of Michigan at Ann Arbor |
| 5-R01-EB029750-04 |
Engineering S. typhimurium for metastatic colorectal cancer |
Tal Danino |
Columbia Univ New York Morningside |
| 5-R01-EB030340-04 |
Model-guided design of next-generation bacterial therapeutics to treat cardiovascular disease |
Ophelia Venturelli |
University of Wisconsin-Madison |
| 5-R01-EB034302-02 |
Programmable encapsulation systems to improve delivery of therapeutic bacteria |
Tal Danino |
Columbia Univ New York Morningside |
| 1-R01-EB037112-01 |
Programming cellular behavior by mechanical forces |
Julien Berro |
Yale University |
| 5-DP1-EB033154-04 |
Sonogenetic Remote Control of Cellular Function |
Mikhail Shapiro |
California Institute of Technology |
| 1-R56-EB036090-01 |
Synthetic Genetic Controller Circuits for Transcription Factor-Directed Differentiation |
Domitilla Del Vecchio |
Massachusetts Institute of Technology |
| 5-R01-EB033821-02 |
Synthetic vascularization and regeneration in engineered tissues |
Christopher Chen |
Boston University (Charles River Campus) |
